• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗凝血酶全氟化碳纳米粒的制备及表征。

Formulation and Characterization of Antithrombin Perfluorocarbon Nanoparticles.

机构信息

The USF Health Heart Institute, University of South Florida, Tampa, FL, USA.

College of Pharmacy, University of South Florida, Tampa, FL, USA.

出版信息

Methods Mol Biol. 2020;2118:111-120. doi: 10.1007/978-1-0716-0319-2_8.

DOI:10.1007/978-1-0716-0319-2_8
PMID:32152974
Abstract

Thrombin, a major protein involved in the clotting cascade by the conversion of inactive fibrinogen to fibrin, plays a crucial role in the development of thrombosis. Antithrombin nanoparticles enable site-specific anticoagulation without increasing bleeding risk. Here we outline the process of making and the characterization of bivalirudin and D-phenylalanyl-L-prolyl-L-arginyl-chloromethyl ketone (PPACK) nanoparticles. Additionally, the characterization of these nanoparticles, including particle size, zeta potential, and quantification of PPACK/bivalirudin loading, is also described.

摘要

凝血酶是凝血级联反应中涉及的主要蛋白质,可将无活性的纤维蛋白原转化为纤维蛋白,在血栓形成的发展中起着至关重要的作用。抗凝血酶纳米颗粒能够实现靶向抗凝而不增加出血风险。本文概述了制备和鉴定水蛭素和 D-苯丙氨酰-L-脯氨酰-L-精氨酰-氯甲基酮(PPACK)纳米颗粒的过程。此外,还描述了这些纳米颗粒的特性,包括粒径、zeta 电位和 PPACK/水蛭素载药量的定量。

相似文献

1
Formulation and Characterization of Antithrombin Perfluorocarbon Nanoparticles.抗凝血酶全氟化碳纳米粒的制备及表征。
Methods Mol Biol. 2020;2118:111-120. doi: 10.1007/978-1-0716-0319-2_8.
2
Antithrombin nanoparticles inhibit stent thrombosis in ex vivo static and flow models.抗凝血酶纳米颗粒在体外静态和流动模型中抑制支架内血栓形成。
J Vasc Surg. 2016 Nov;64(5):1459-1467. doi: 10.1016/j.jvs.2015.08.086. Epub 2015 Oct 17.
3
The effect of antithrombin III-independent thrombin inhibitors and heparin on fibrin accretion onto fibrin-coated polyethylene.抗凝血酶III非依赖性凝血酶抑制剂和肝素对纤维蛋白在纤维蛋白包被的聚乙烯上沉积的影响。
Thromb Haemost. 1993 Feb 1;69(2):130-4.
4
Thrombin inhibitors and anti-coagulants on thrombin-induced embolisation in rabbit cranial vasculature.凝血酶抑制剂和抗凝剂对兔颅脑血管中凝血酶诱导栓塞的作用。
Eur J Pharmacol. 1994 Oct 24;264(2):183-90. doi: 10.1016/0014-2999(94)00464-1.
5
Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors.与凝块结合的凝血酶可免受肝素-抗凝血酶III的抑制,但易被不依赖抗凝血酶III的抑制剂灭活。
J Clin Invest. 1990 Aug;86(2):385-91. doi: 10.1172/JCI114723.
6
Visual compatibility of bivalirudin with selected drugs.比伐卢定与选定药物的视觉相容性。
Am J Health Syst Pharm. 2004 Sep 1;61(17):1774, 1776. doi: 10.1093/ajhp/61.17.1774.
7
Bivalirudin: a review of the pharmacology and clinical application.比伐芦定:药理学与临床应用综述
Expert Rev Cardiovasc Ther. 2010 Dec;8(12):1673-81. doi: 10.1586/erc.10.158.
8
Inhibition of Thrombin With PPACK-Nanoparticles Restores Disrupted Endothelial Barriers and Attenuates Thrombotic Risk in Experimental Atherosclerosis.用PPACK纳米颗粒抑制凝血酶可恢复实验性动脉粥样硬化中受损的内皮屏障并降低血栓形成风险。
Arterioscler Thromb Vasc Biol. 2016 Mar;36(3):446-55. doi: 10.1161/ATVBAHA.115.306697. Epub 2016 Jan 14.
9
Interruption of acute platelet-dependent thrombosis by the synthetic antithrombin D-phenylalanyl-L-prolyl-L-arginyl chloromethyl ketone.合成抗凝血酶D-苯丙氨酰-L-脯氨酰-L-精氨酰氯甲基酮对急性血小板依赖性血栓形成的阻断作用。
Proc Natl Acad Sci U S A. 1988 May;85(9):3184-8. doi: 10.1073/pnas.85.9.3184.
10
Construction and characterization of novel hirulog variants with antithrombin and antiplatelet activities.具有抗凝血酶和抗血小板活性的新型水蛭素变体的构建与表征
Protein Pept Lett. 2014;21(1):69-74. doi: 10.2174/092986652101131219111458.